Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specifying and Treating the Anxiety Phenotype in Autism Spectrum Disorder

NCT03279471 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT03279471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03279471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specifying and Treating the Anxiety Phenotype in Autism Spectrum Disorder
Lead sponsor
University of California, Davis
Phase
Phase 2
Overall status
Completed
Start date
October 1, 2017
Completion date
February 22, 2023
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, autism spectrum disorder